The National Cancer Institute has scheduled a closed meeting on December 10, 2024, to evaluate requests for resources for developing new cancer treatments. The meeting is closed to protect sensitive information such as trade secrets and personal data. Due to exceptional circumstances, like the unexpected volume of project requests, the notice for this meeting was issued less than 15 days in advance. Missing this meeting could cause significant delays in cancer research funding and clinical trials.
Simple Explanation
The National Cancer Institute is having a private meeting to decide which new cancer treatments to support, but they told everyone about the meeting later than they usually should because they got more requests than expected. They keep some stuff secret to protect important details and people's privacy.